Resources
About Us
HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Global Forecast to 2029
Report ID: MRHC - 104625 Pages: 233 Oct-2022 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours Download Free Sample ReportThe HLA Typing Market is expected to grow at a CAGR of 5.6% from 2022 to 2029 to reach $1.90 billion by 2029. The increasing number of organ transplants, increasing prevalence of chronic and infectious diseases, and technological advancements in the molecular assays used for HLA typing are expected to propel the global HLA typing market. The availability of funding for HLA typing research is also expected to positively impact the HLA typing market. Furthermore, the increasing awareness amongst people regarding organ donations offers an opportunity for the growth of the HLA typing market.
However, the high costs associated with molecular assays related to HLA typing and the huge gap between organ donations and organs required for transplantation pose a major challenge for the HLA typing market.
Growing Number of Organ Transplants Fuels the HLA Typing Market Growth
Human leukocyte antigen (HLA) molecules are expressed in almost all nucleated cells. These molecules trigger an immune response responsible for the rejection of transplanted grafts. The ideal condition for a successful transplant is that the HLA genes in both the donor and recipient match as closely as possible. Hence, HLA matching is an essential test to ensure a successful transplant and reduce the possibility of graft rejection. The demand for organ transplants has increased over the last decade. For instance, in 2021, organ transplants increased to 33.25 per million people from 20.49 transplants in 2019 (Source: Global Observatory on Donation and Transplantation).
This demand can be attributed to the increasing incidence of organ failure and the high success rate of transplants due to new immunosuppressants, robot-assisted organ transplantation, organ-specific solutions (reagents) for preservation, and logistics management in organ procurement. As HLA matching is an essential aspect of transplant diagnostics in checking the compatibility between the donor’s and recipient’s HLA genes, the need for high organ transplantation success rates is expected to drive the global HLA typing market.
Click here to: Get Free Sample Pages of this Report
Molecular Assays for HLA Matching: Preferred Method of Typing
Before 1990, serotyping was critical in HLA typing for organ transplants. However, most of the HLA antisera are polyclonal in nature and result in cross-reactions, making it complicated to differentiate antigens with subtle differences, which may result in incorrect identification. In addition, numerous factors, such as the time required to transport blood samples and the excessive number of immature cells, affect the serotyping results. These limitations of serotyping for HLA drove the adoption of molecular assays.
Molecular technologies have substituted conventionally used serological assays. Molecular technologies provide higher resolution, accuracy, sensitivity, and specificity in HLA typing. Non-molecular techniques utilize polyclonal antisera that lead to cross-reactions, which makes it difficult to differentiate antigens with subtle differences, leading to inaccuracy. Serological methods are used only for low-resolution typing, whereas molecular methods are used for high-resolution typing.
Based on Technology, the Molecular Assay Segment is Estimated to Grow at a CAGR of 5.6% During the Forecast Period
The growth of the molecular assay segment is attributed to advancements in molecular technologies, companies focusing on developing and launching products based on new technologies, and the benefits of molecular technologies compared to non-molecular technologies. The molecular assay techniques, such as next-generation sequencing, provide high-resolution HLA genotyping. The combination of HLA sequencing (for increased sequence length) and advanced bioinformatics tools has enabled the accurate HLA genotyping of variants and full-length HLA haplotypes without phase ambiguity. Moreover, HLA genotyping overcomes many of the disadvantages of using conventional technologies, such as the inability to distinguish between different alleles at a locus and the need for multiple endonucleases to break down nucleotide chains in two or more fragments.
Based on Product, the Consumables Segment is Estimated to Dominate the HLA Typing Market in 2022
Recurrent use of the consumables, availability of diverse tests, and companies focused on launching new assays contribute to the large share of this segment. For instance, in 2021, Versiti, Inc. (U.S.) launched a test for the detection of loss of heterozygosity in the HLA region. This test is useful to gain information on patients with post-transplant relapse. Test kits & assays offered by major players operating in the HLA typing market are based on several technologies and are designed to be used with specific platforms. For instance, HLA SSP kits offered by Bio-Rad Laboratories (U.S.) are based on PCR systems. Similarly, NGSgo-MX-11-3 amplification kits are designed to be used with next-generation sequencing NGS platforms.
Based on End User, the Diagnostic Laboratories Segment is Projected to Register the Highest Growth in the HLA Typing Market by 2029
The factors propelling this segment's growth include outsourcing laboratory services by hospitals and transplant centers and a consolidation trend among diagnostics laboratories. Transplant centers and hospitals partner with diagnostic laboratories to undertake diagnostic procedures. For instance, SBC’s Histocompatibility & Immunogenetics Laboratory (HLA LAB) (U.S.) carries out testing for the Stanford Hospital (U.S.) and Lucile Packard Children’s Hospital (U.S.). Owing to the outsourcing of laboratory services, the diagnostics centers perform HLA typing, contributing to a higher revenue share.
China: Second Largest Share Holding Country
In 2022, China is expected to account for the second largest share of 9% of the market, after the U.S. China faced a great shortage of organs for transplants after the government stopped harvesting organs from executed prisoners in 2015. However, the Chinese government is taking steps toward reforming organ donation and procurement. For instance, in 2021, the Government of China introduced the Human Organ Transplant Act. As a result, the country saw an increase in organ donation volunteers by 45% since the start of the COVID-19 pandemic. As of June 2021, 1.77 million volunteers registered for organ donation at the Organ Transportation Development Foundation (COTDF) (China). The increase in organ donation volunteers is expected to increase the adoption of HLA typing in the country.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments in leading industry market players over the past four years. The key players profiled in the global HLA Typing Market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Genome Diagnostics B.V. (GenDx) (Netherlands), Illumina, Inc. (U.S.), CareDx (U.S.), Immucor Inc. (U.S.), TBG Diagnostics Limited (Australia), BAG Diagnostic GmbH (Germany), Omixon Inc. (Hungary), Luminex Corporation (U.S.), inno-train Diagnostik GmbH (Germany), Pacific Biosciences of California, Inc. (U.S.), and Fujirebio Holdings, Inc. (Japan). The global HLA typing market is fragmented in nature and dominated by four top players, namely, Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Illumina, Inc. (U.S.). In 2021, these players collectively accounted for a share of 20%–25% of the HLA typing market.
Product launches & enhancement were the most preferred growth strategies adopted by key players, accounting for the largest share of the total strategic developments between 2019 and 2022. These strategies enabled companies to broaden their product portfolios, advance the capabilities of their existing products, cater to the changing demands of users, and ensure a competitive edge in the global HLA typing market. The leading players that actively adopted these strategies were Thermo Fisher Scientific, Inc. (U.S.), CareDx Inc. (U.S.), Genome Diagnostics B.V. (Netherlands), Immucor, Inc. (U.S.), and Omixon, Inc. (Hungary).
Scope of the Report:
HLA Typing Market, by Product
HLA Typing Market, by Technology
HLA Typing Market, by Application
HLA Typing Market, by End Users
HLA Typing Market, by Geography
Key questions answered in the report:
The HLA Typing Market covers the market size & forecasts of the consumables, instruments, and software & services used for HLA typing. The HLA typing market studied in this report involves the value analysis of various segments and sub-segments of the HLA typing market at regional and country levels.
The global HLA Typing Market is projected to reach $1.90 billion by 2029, at a CAGR of 5.6% during the forecast period.
Based on the products, in 2022, the consumables segment accounted for the largest share of the HLA Typing Market. Recurrent use of the consumables, availability of diverse tests, and companies focused on launching new assays contribute to this segment's large share.
Based on the technology, the molecular assay segment is projected to create more traction owing to the advancements in molecular technologies, companies focusing on developing and launching products based on new technologies, and the benefits of molecular technologies compared to non-molecular technologies.
The increasing organ transplants and technological advancement in the molecular assays used for HLA typing are expected to propel the global HLA typing market. In addition to that, the increasing awareness amongst people regarding organ donations offers an opportunity to HLA typing market players.
The key players operating in the global HLA Typing Market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Genome Diagnostics B.V. (GenDx) (Netherlands), Illumina, Inc. (U.S.), CareDx (U.S.), Immucor Inc. (U.S.), TBG Diagnostics Limited (Australia), BAG Diagnostic GmbH (Germany), Omixon Inc. (Hungary), Luminex Corporation (U.S.), inno-train Diagnostik GmbH (Germany), Pacific Biosciences of California, Inc. (U.S.), and Fujirebio Holdings, Inc. (Japan).
China and India are projected to offer significant growth opportunities for the vendors in this market owing to the growing number of organ transplants, high prevalence of autoimmune diseases, and government support for R&D of advanced HLA typing products.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Number of organ Transplants
4.2.2. Technological Advancements in HLA Typing
4.3. Restraints
4.3.1. High Cost of Instruments Required to HLA Typing
4.4. Opportunities
4.4.1. Increasing Awareness Regarding the Importance of Organ Donations
4.5. Challenges
4.5.1. Gap Between Organ Donations and Organ Receivers
4.6. Impact Analysis of COVID-19
5. Global HLA Typing Market, by Product
5.1. Introduction
5.2. Consumables
5.3. Instruments
5.4. Software & Services
6. Global HLA Typing Market, by Technology
6.1. Introduction
6.2. Molecular Technologies
6.2.1. PCR-based Molecular Techniques
6.2.1.1. Sequence-specific Primers
6.2.1.2. Sequence-specific Oligonucleotide
6.2.1.3. Other PCR-based Molecular Techniques
6.2.2. Sequencing-based Molecular Technologies
6.2.2.1. Sangers Sequencing
6.2.2.2. Next-generation Sequencing
6.2.2.3. Pyrosequencing
6.2.3. DNA Microarray
6.3. Non-molecular Technologies
7. Global HLA Typing Market, by Application
7.1. Introduction
7.2. Diagnostics
7.2.1. Donor Recipient Cross-Matching
7.2.2. Transfusion Therapy
7.2.3. Other Diagnostic Applications
7.3. Research
8. Global HLA Typing Market, by End User
8.1. Introduction
8.2. Diagnostics Laboratories
8.3. Hospitals & Transplant Centers
8.4. Academic & Research Institutes
9. HLA Typing Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLA)
9.6. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
11. Company Profiles (Business Overview, Financial Snapshot, Product Benchmarking, and Strategic Developments)
11.1. Becton, Dickinson and Company (BD)
11.2. Bio-Rad Laboratories, Inc.
11.3. Thermo Fisher Scientific Inc.
11.4. QIAGEN N.V.
11.5. Illumina Inc.
11.6. CareDx, Inc.
11.7. Genome Diagnostics B.V. (GenDx)
11.8. TBG Diagnostics Limited (TDL)
11.9. BAG Diagnostics GmbH
11.10. Omixon Inc.
11.11. Luminex Corporation
11.12. inno-train Diagnostik GmbH
11.13. Pacific Biosciences of California, Inc.
11.14. Fujirebio Holdings, Inc.
12. Appendix
12.1. Questionnaire
12.2. Available Customization
List of Tables
Table 1 Global HLA Typing Market: Impact Analysis of Market Drivers (2022–2029)
Table 2 Global HLA Typing Market: Impact Analysis of Market Restraints (2022–2029)
Table 3 Instrument and Sequencing Costs
Table 4 Global HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 5 Some of The Key Companies Offering HLA Typing Consumables
Table 6 Global HLA Typing Market Size for Consumables, by Country/Region, 2020–2029 (USD Million)
Table 7 Some of The Key Companies Offering Instruments for HLA Typing
Table 8 Global HLA Typing Market Size for Instruments, by Country/Region, 2020–2029 (USD Million)
Table 9 Some of The Key Companies Offering Software & Services for HLA Typing
Table 10 Global HLA Typing Market Size for Software & Services, by Country/Region, 2020–2029 (USD Million)
Table 11 Global HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 12 Global HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 13 Global HLA Typing Market Size for Molecular Technologies, by Country/Region, 2020–2029 (USD Million)
Table 14 Global HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 15 Global HLA Typing Market Size For PCR-Based Molecular Techniques, by Country/Region, 2020–2029 (USD Million)
Table 16 Key Companies Offering SSP-PCR Tests for HLA Typing
Table 17 Global HLA Typing Market Size for Sequence-Specific Primers, by Country/Region, 2020–2029 (USD Million)
Table 18 Key Companies Offering SSO- PCR Tests & Systems for HLA Typing
Table 19 Global HLA Typing Market Size for Sequence-Specific Oligonucleotides, by Country/Region, 2020–2029 (USD Million)
Table 20 Key Companies Offering Other PCR-Based Molecular Techniques for HLA Typing
Table 21 Global HLA Typing Market Size for Other PCR-Based Molecular Techniques, by Country/Region, 2020–2029 (USD Million)
Table 22 Global HLA Typing Market Size for DNA Microarray, by Country/Region, 2020–2029 (USD Million)
Table 23 Global HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 24 Global HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Country/Region, 2020–2029 (USD Million)
Table 25 Global HLA Typing Market Size for Sanger Sequencing, by Country/Region, 2020–2029 (USD Million)
Table 26 Key Companies Offering NGS-Based Products for HLA Typing
Table 27 Global HLA Typing Market Size for Next-Generation Sequencing, by Country/Region, 2020–2029 (USD Million)
Table 28 Global HLA Typing Market Size for Pyrosequencing, by Country/Region, 2020–2029 (USD Million)
Table 29 Key Companies Offering Non-Molecular Technologies for HLA Typing
Table 30 Global HLA Typing Market Size for Non-Molecular Technologies, by Country/Region, 2020–2029 (USD Million)
Table 31 Global HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 32 Global HLA Typing Market Size for Diagnostics, by Type, 2020–2029 (USD Million)
Table 33 Global HLA Typing Market Size for Diagnostics, by Country/Region, 2020–2029 (USD Million)
Table 34 Global HLA Typing Market Size for Donor-Recipient Cross-Matching, by Country/Region, 2020–2029 (USD Million)
Table 35 Global HLA Typing Market Size for Transfusion Therapy, by Country/Region, 2020–2029 (USD Million)
Table 36 Global HLA Typing Market Size for Other Diagnostic Applications by Country/Region, 2020–2029 (USD Million)
Table 37 Global HLA Typing Market Size for Research, by Country/Region, 2020–2029 (USD Million)
Table 38 Global HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 39 Global HLA Typing Market Size for Hospitals & Transplant Centers, by Country/Region, 2020–2029 (USD Million)
Table 40 Global HLA Typing Market Size for Diagnostic Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 41 Government Organizations Funding Cancer Research, by Country
Table 42 Global HLA Typing Market Size for Academic & Research Institutes, by Country/Region, 2020–2029 (USD Million)
Table 43 Global HLA Typing Market Size, by Country/Region, 2020–2029 (USD Million)
Table 44 North America: HLA Typing Market Size, by Country, 2020–2029 (USD Million)
Table 45 North America: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 46 North America: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 47 North America: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 48 North America: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 49 North America: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 50 North America: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 51 North America: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 52 North America: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 53 U.S.: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 54 U.S.: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 55 U.S.: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 56 U.S.: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 57 U.S.: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 58 U.S.: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 59 U.S.: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 60 U.S.: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 61 Canada: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 62 Canada: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 63 Canada: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 64 Canada: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 65 Canada: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 66 Canada: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 67 Canada: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 68 Canada: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 69 Europe: HLA Typing Market Size, by Country, 2020–2029 (USD Million)
Table 70 Europe: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 71 Europe: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 72 Europe: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 73 Europe: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 74 Europe: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 75 Europe: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 76 Europe: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 77 Europe: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 78 Germany: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 79 Germany: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 80 Germany: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 81 Germany: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 82 Germany: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 83 Germany: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 84 Germany: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 85 Germany: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 86 France: Recent Research Conducted on HLA Typing
Table 87 France: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 88 France: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 89 France: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 90 France: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 91 France: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 92 France: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 93 France: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 94 France: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 95 U.K.: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 96 U.K.: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 97 U.K.: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 98 U.K.: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 99 U.K.: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 100 U.K.: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 101 U.K.: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 102 U.K.: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 103 Italy: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 104 Italy: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 105 Italy: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 106 Italy: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 107 Italy: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 108 Italy: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 109 Italy: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 110 Italy: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 111 Spain: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 112 Spain: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 113 Spain: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 114 Spain: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 115 Spain: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 116 Spain: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 117 Spain: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 118 Spain: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 119 Rest of Europe: Actual Deceased Organ Donors Rate (2016 Vs 2021)
Table 120 Rest of Europe: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 121 Rest of Europe: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 122 Rest of Europe: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 123 Rest of Europe: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 124 Rest of Europe: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 125 Rest of Europe: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 126 Rest of Europe: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 127 Rest of Europe: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 128 Asia-Pacific: HLA Typing Market Size, by Country, 2020–2029 (USD Million)
Table 129 Asia-Pacific: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 130 Asia-Pacific: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 131 Asia-Pacific: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 132 Asia-Pacific: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 133 Asia-Pacific: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 134 Asia-Pacific: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 135 Asia-Pacific: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 136 Asia-Pacific: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 137 Japan: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 138 Japan: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 139 Japan: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 140 Japan: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 141 Japan: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 142 Japan: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 143 Japan: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 144 Japan: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 145 China: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 146 China: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 147 China: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 148 China: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 149 China: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 150 China: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 151 China: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 152 China: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 153 Organ Transplant in India Comparison (2019 Vs 2020)
Table 154 India: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 155 India: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 156 India: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 157 India: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 158 India: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 159 India: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 160 India: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 161 India: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 162 Rest of Asia-Pacific: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 163 Rest of Asia-Pacific: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 164 Rest of Asia-Pacific: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 165 Rest of Asia-Pacific: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 166 Rest of Asia-Pacific: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 167 Rest of Asia-Pacific: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 168 Rest of Asia-Pacific: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 169 Rest of Asia-Pacific: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 170 Latin America: HLA Typing Market Size, by Country, 2020–2029 (USD Million)
Table 171 Latin America: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 172 Latin America: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 173 Latin America: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 174 Latin America: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 175 Latin America: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 176 Latin America: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 177 Latin America: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 178 Latin America: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 179 Brazil: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 180 Brazil: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 181 Brazil: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 182 Brazil: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 183 Brazil: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 184 Brazil: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 185 Brazil: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 186 Brazil: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 187 Mexico: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 188 Mexico: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 189 Mexico: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 190 Mexico: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 191 Mexico: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 192 Mexico: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 193 Mexico: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 194 Mexico: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 195 Rest of Latin America: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 196 Rest of Latin America: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 197 Rest of Latin America: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 198 Rest of Latin America: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 199 Rest of Latin America: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 200 Rest of Latin America: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 201 Rest of Latin America: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 202 Rest of Latin America: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 203 HLA Typing Test Services Offered by Dubai Health Authority
Table 204 Middle East & Africa: HLA Typing Market Size, by Product, 2020–2029 (USD Million)
Table 205 Middle East & Africa: HLA Typing Market Size, by Technology, 2020–2029 (USD Million)
Table 206 Middle East & Africa: HLA Typing Market Size for Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 207 Middle East & Africa: HLA Typing Market Size For PCR-Based Molecular Techniques, by Type, 2020–2029 (USD Million)
Table 208 Middle East & Africa: HLA Typing Market Size for Sequencing-Based Molecular Technologies, by Type, 2020–2029 (USD Million)
Table 209 Middle East & Africa: HLA Typing Market Size, by Application, 2020–2029 (USD Million)
Table 210 Middle East & Africa: HLA Typing Market Size for Diagnostic Applications, by Type, 2020–2029 (USD Million)
Table 211 Middle East & Africa: HLA Typing Market Size, by End User, 2020–2029 (USD Million)
Table 212 Recent Developments, By Company (2019–2022)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global HLA Typing Market Size, by Product Type, 2022 Vs. 2029 (USD Million)
Figure 8 Global HLA Typing Market Size, by Technology, 2022 Vs. 2029 (USD Million)
Figure 9 Global HLA Typing Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 10 Global HLA Typing Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 11 HLA Typing Market Size, By Geography
Figure 12 Market Dynamics
Figure 13 Global Organ Transplants Per Million Population (2015–2021)
Figure 14 Number of People on The Organ Transplant Waiting List Vs. Transplants Performed (Deceased Donors) By Eurotransplant (2020)
Figure 15 Global HLA Typing Market Size, by Product, 2022–2029 (USD Million)
Figure 16 Global HLA Typing Market Size, by Technology, 2022 Vs. 2029 (USD Million)
Figure 17 Global HLA Typing Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 18 Number of Deceased Organ Donors (2012–2021)
Figure 19 Number of Regional Organ Transplants (2015 Vs. 2021)
Figure 20 Estimated Number of New Cancer Cases, by Region (2020–2040)
Figure 21 Global HLA Typing Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 22 Number of Organ Transplantation Procedures, by Region (2020)
Figure 23 U.S. National Institutes of Health Budgets (2019–2021)
Figure 24 Global HLA Typing Market Size, by Geography, 2022–2029 (USD Million)
Figure 25 North America: HLA Typing Market Snapshot
Figure 26 U.S.: Hematopoietic Cell Transplants (2016–2020)
Figure 27 Europe: HLA Typing Market Snapshot
Figure 28 Cancer Prevalence in Germany (2020–2030)
Figure 29 Germany: Organ Donations (2015–2021)
Figure 30 Kidney Transplants in France (2010 Vs 2015 Vs 2019)
Figure 31 Italy: Number of New Cancer Cases (2018 Vs 2020)
Figure 32 Number of Organ Transplants in Italy (2010–2021)
Figure 33 Number of Organ Transplants in Spain, By Type, 2016–2021
Figure 34 Asia: Cancer Incidence (2020–2035)
Figure 35 Asia-Pacific: HLA Typing Market Size Snapshot
Figure 36 Number of Organ Transplants in Japan (2011 Vs 2017 Vs 2020)
Figure 37 Number of Cancer Cases in China (2020–2040)
Figure 38 Latin America: HLA Typing Market Snapshot
Figure 39 Brazil: Kidney Transplants (Per Million Population) (Deceased Donors) (2010–2020)
Figure 40 Organ Transplants in Mexico, 2016 Vs 2021
Figure 41 Deceased Organ Donation Rate in PMP In Latin American Countries (2021)
Figure 42 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 43 Hla Typing: Competitive Benchmarking, by Product
Figure 44 Global HLA Typing Market Share Analysis, by Key Players, 2021 (%)
Figure 45 Becton, Dickinson and Company: Financial Overview (2021)
Figure 46 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 47 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 48 Qiagen N.V.: Financial Overview (2021)
Figure 49 Illumina, Inc.: Financial Overview (2021)
Figure 50 Caredx, Inc.: Financial Overview (2021)
Figure 51 TBG Diagnostics Limited (Tdl): Financial Overview (2020)
Figure 52 Pacific Biosciences of California, Inc.: Financial Overview (2021)
Figure 53 H.U. Group Holdings, Inc.: Financial Overview (2020)
Published Date: Mar-2021
Published Date: Nov-2024
Published Date: Oct-2013
Published Date: Aug-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates